Jeffrey Zhang Selected Research

ramelteon (Rozerem)

4/2009	Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
3/2009	The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.
8/2008	Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.
8/2007	Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
5/2007	A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
6/2006	Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
1/2006	An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Zhang Research Topics

Disease

6	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2009 - 01/2006
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2019
3	Infections 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 01/2020
2	COVID-19 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2018
2	Neoplasms (Cancer) 07/2021 - 01/2017
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2019 - 10/2018
2	Pulmonary Arterial Hypertension 01/2019 - 10/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2009 - 08/2008
2	Apnea 03/2009 - 08/2008
1	Disease Progression 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Neutropenia 12/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2021
1	Olfaction Disorders (Cacosmia) 01/2021
1	Cognitive Dysfunction 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Infectious Arthritis (Septic Arthritis) 01/2020
1	Osteomyelitis 01/2020
1	Coinfection 11/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Mitral Valve Prolapse 01/2019
1	Cardiotoxicity 10/2018
1	Carcinoma (Carcinomatosis) 02/2016
1	Clinical Deterioration 01/2016
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2010
1	Pseudarthrosis (Pseudoarthrosis) 02/2005

Drug/Important Bio-Agent (IBA)

7	ramelteon (Rozerem)FDA Link 04/2009 - 01/2006
4	EdaravoneIBA 01/2022 - 01/2019
3	MT2 Melatonin ReceptorIBA 08/2007 - 01/2006
2	zegocractinIBA 01/2022 - 01/2020
2	Calcium Release Activated Calcium ChannelsIBA 01/2022 - 01/2020
2	CalciumIBA 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 01/2020
2	Biosimilar PharmaceuticalsIBA 12/2021 - 07/2021
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2018
2	Melatonin Receptors (Melatonin Receptor)IBA 03/2009 - 08/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	pegfilgrastim (Neulasta)FDA Link 12/2021
1	insulin receptor-related receptor (IRR)IBA 07/2021
1	Rituximab (Mabthera)FDA Link 07/2021
1	Therapeutic UsesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	KetonesIBA 01/2021
1	quinolineIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	CaspasesIBA 01/2021
1	quinoline-val-asp(OMe)-CH2-OPHIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	LuciferasesIBA 11/2019
1	Trastuzumab (Herceptin)FDA Link 10/2018
1	Pharmaceutical PreparationsIBA 02/2016
1	Neutralizing AntibodiesIBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Erythropoietin FDA Link 01/2016
1	Clomiphene (Clomifene)FDA LinkGeneric 10/2010
1	Metformin (Glucophage)FDA LinkGeneric 10/2010
1	dimemorfan (AT 17)IBA 05/2007
1	MelatoninIBA 05/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2021
1	Immunotherapy 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Therapeutics 01/2017
1	Arthrodesis 02/2005